Literature DB >> 24184920

Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy.

Jan A Gorter1, Anand Iyer2, Ian White3, Anna Colzi4, Erwin A van Vliet1, Sanjay Sisodiya5, Eleonora Aronica6.   

Abstract

Since aberrant miRNA expression has been implicated in numerous brain diseases, we studied miRNA expression and miRNA regulation of important signaling pathways during temporal lobe epileptogenesis in order to identify possible targets for epilepsy therapy. The temporal profile of miRNA expression was analyzed in three brain regions (CA1; dentate gyrus, DG; parahippocampal cortex, PHC) associated with epileptogenesis in a rat model for temporal lobe epilepsy. Tissue was obtained after electrically-induced status epilepticus (SE) at 1day (n=5), 1week (n=5) and 3-4months (n=5), and compared with control tissue (n=10) using the Exiqon microRNA arrays which contain capture probes targeting all miRNAs for rat (p<0.01, and a 1.5 fold up- or downregulation). Expression of three blood plasma miRNAs from the same group of rats was also investigated in rats in order to determine whether plasma miRNAs could serve as potential biomarkers of the epileptogenic process. Molecular pathways potentially altered by the expression of multiple miRNAs were identified using a web-based algorithm, DIANA. In CA1 and DG, more upregulated than downregulated miRNAs were present during each stage after SE. The highest numbers of upregulated miRNAs were encountered during the chronic stage in the DG. In PHC, a high number of downregulated miRNAs were detected. Key pathways involved, based upon quantitatively altered miRNA expression were: axon guidance, MAPK signaling pathway, focal adhesion, TGFβ, ErbB-, Wnt- and mTOR signaling, and regulation of actin skeleton. Expression of plasma miRNAs was differentially regulated after induction of SE. This study identified several signaling pathways possibly involved in temporal lobe epileptogenesis, not previously indicated by RNA microarray studies. These include miRNAs that regulate the ErbB and Wnt pathways and focal adhesion, which may represent interesting new targets for therapeutic interventions.
© 2013.

Entities:  

Keywords:  Array; DG; ERK; Epileptogenesis; Hippocampus; JNK; LIM domain kinase 1; Limk1; MAPK; MEF2C; MEK1; PHC; Pathways; RIN; RNA Integrity Number; Rat; SE; SV2A; TGFβ; TLE; c-JUN N-terminal kinase; dentate gyrus; extracellular signal-regulated kinase; mTOR; mammalian target of rapamycin; miRNA; miRNAs; microRNAs; mitogen-activated protein kinase; mitogen-activated protein kinase kinase; myocyte enhancer factor 2C; parahippocampal cortex; status epilepticus; synaptic vesicle protein 2A; temporal lobe epilepsy; transforming growth factor beta

Mesh:

Substances:

Year:  2013        PMID: 24184920     DOI: 10.1016/j.nbd.2013.10.026

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  73 in total

1.  miR-218-2 regulates cognitive functions in the hippocampus through complement component 3-dependent modulation of synaptic vesicle release.

Authors:  Si-Yao Lu; Chong-Lei Fu; Liang Liang; Bo Yang; Wei Shen; Qiu-Wen Wang; Yun Chen; Yan-Fen Chen; Yao-Nan Liu; Lin Zhu; Jieqing Zhao; Wei Shi; Shuangli Mi; Jun Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

2.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

3.  MicroRNA-210 Regulates Dendritic Morphology and Behavioural Flexibility in Mice.

Authors:  Jess Nithianantharajah; Charles Claudianos; Michelle Watts; Gabrielle Williams; Jing Lu
Journal:  Mol Neurobiol       Date:  2020-11-09       Impact factor: 5.590

4.  2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.

Authors:  Aristea S Galanopoulou; Michael Wong; Devin Binder; Adam L Hartman; Elizabeth M Powell; Avtar Roopra; Richard Staba; Annamaria Vezzani; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

5.  Harmonization of pipeline for preclinical multicenter plasma protein and miRNA biomarker discovery in a rat model of post-traumatic epileptogenesis.

Authors:  Alaa Kamnaksh; Noora Puhakka; Idrish Ali; Gregory Smith; Roxanne Aniceto; Jesse McCullough; Shalini Das Gupta; Xavier Ekolle Ndode-Ekane; Rhys Brady; Pablo Casillas-Espinosa; Matt Hudson; Cesar Santana-Gomez; Riikka Immonen; Pedro Andrade de Abreu; Nigel Jones; Sandy Shultz; Richard J Staba; Terence J O'Brien; Denes Agoston; Asla Pitkänen
Journal:  Epilepsy Res       Date:  2018-11-26       Impact factor: 3.045

6.  miR-124-3p is a chronic regulator of gene expression after brain injury.

Authors:  Niina Vuokila; Katarzyna Lukasiuk; Anna Maria Bot; Erwin A van Vliet; Eleonora Aronica; Asla Pitkänen; Noora Puhakka
Journal:  Cell Mol Life Sci       Date:  2018-08-28       Impact factor: 9.261

Review 7.  Epileptogenesis.

Authors:  Asla Pitkänen; Katarzyna Lukasiuk; F Edward Dudek; Kevin J Staley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

Review 8.  MicroRNA and epilepsy: profiling, functions and potential clinical applications.

Authors:  David C Henshall
Journal:  Curr Opin Neurol       Date:  2014-04       Impact factor: 5.710

Review 9.  Biomarkers for epileptogenesis and its treatment.

Authors:  Jerome Engel; Asla Pitkänen
Journal:  Neuropharmacology       Date:  2019-08-01       Impact factor: 5.250

Review 10.  MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application.

Authors:  Durgesh Tiwari; Katrina Peariso; Christina Gross
Journal:  Dev Dyn       Date:  2017-10-04       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.